PRESS RELEASE published on 10/16/2024 at 11:55, 1 year 1 month ago APONTIS PHARMA and Zentiva entered into partnership for future growth – Zentiva will launch a voluntary public purchase offer APONTIS PHARMA partners with Zentiva for growth, offering shareholders EUR 10.00 per share in a voluntary public purchase offer. Zentiva aims for majority stake and strategic collaboration Partnership Growth APONTIS PHARMA Voluntary Offer Zentiva
PRESS RELEASE published on 10/16/2024 at 11:50, 1 year 1 month ago EQS-Adhoc: APONTIS PHARMA and Zentiva enter into investment agreement – Zentiva will launch a voluntary public purchase offer APONTIS PHARMA and Zentiva enter into investment agreement for voluntary public purchase offer at EUR 10.00 per share in cash. Zentiva aims to support future growth of APONTIS PHARMA APONTIS PHARMA Investment Agreement Voluntary Purchase Offer Zentiva EUR 10.00
BRIEF published on 10/08/2024 at 13:05, 1 year 1 month ago EV Nickel Discovers New High-Grade Nickel Zones Extending Carlang Trend Diamond Drill Program Nickel Exploration Mineralization Zones High-grade Nickel Carlang Trend Expansion
PRESS RELEASE published on 10/08/2024 at 13:00, 1 year 1 month ago EV Nickel Intersects 3 New Zones of Mineralization on the Carlang Trend Including Highest Nickel Grades to Date & Significantly Extends Strike Length by 7km EV Nickel Inc. announces successful diamond drill program on CarLang Trend confirming near surface nickel mineralization and identifying 3 new zones of large-scale mineralization over 7km of strike Diamond Drill Program EV Nickel Inc. Nickel Mineralization CarLang Trend Large-scale Mineralization
BRIEF published on 09/04/2024 at 13:05, 1 year 3 months ago EV Nickel Confirms High-Grade Nickel at Langmuir #2 Intersecting Nickel Grades from 1.07% to 5.11% Exploration Nickel Assay Results High-grade Langmuir #2
PRESS RELEASE published on 09/04/2024 at 13:00, 1 year 3 months ago EV Nickel Confirms High-Grade Nickel at Langmuir #2 Intersecting Nickel Grades from 1.07% to 5.11% EV Nickel Inc. reports high-grade nickel intercepts including 5.11% Ni in Langmuir #2 Nickel Zone, with assay results indicating high nickel tenor. Company plans further drilling to advance Canadian nickel supply chain Drilling Program Assay Results EV Nickel Inc. High-grade Nickel Canadian Nickel Supply Chain
BRIEF published on 08/16/2024 at 10:46, 1 year 3 months ago First Berlin Equity Research Reaffirms BUY Rating for APONTIS PHARMA AG First Berlin Equity Research Buy Recommendation APONTIS PHARMA AG H1/24 Results Single Pill Business
PRESS RELEASE published on 08/16/2024 at 10:41, 1 year 3 months ago Original-Research: APONTIS PHARMA AG (von First Berlin Equity Research GmbH): BUY First Berlin Equity Research recommends buying APONTIS PHARMA AG shares with a target price of €17 after solid H1/24 results and positive outlook. Analyst Christian Orquera maintains his BUY rating First Berlin Equity Research Buy Recommendation APONTIS PHARMA AG H1/24 Results Christian Orquera
BRIEF published on 08/09/2024 at 07:35, 1 year 3 months ago APONTIS PHARMA Reports Strong Half-Year Growth in 2024 Revenue Growth APONTIS PHARMA Single Pill Combinations EBITDA Improvement Novartis Cooperation
PRESS RELEASE published on 08/09/2024 at 07:30, 1 year 3 months ago APONTIS PHARMA with profitable revenue growth for Single Pill combinations in the first half of 2024 – forecast for the full year confirmed APONTIS PHARMA reports profitable revenue growth with Single Pill combinations in the first half of 2024. Forecast for full year 2024 confirmed. Earnings and sales improvements noted EBITDA Revenue Growth Forecast APONTIS PHARMA Single Pill Combinations
Published on 12/05/2025 at 02:35, 10 hours 57 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 12 hours 32 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 14 hours 27 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 14 hours 32 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 13:00, 32 minutes ago Zentra Group plc: Posting of Notice of Annual General Meeting
Published on 12/05/2025 at 13:00, 32 minutes ago Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd.
Published on 12/05/2025 at 12:05, 1 hour 27 minutes ago Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
Published on 12/05/2025 at 12:00, 1 hour 32 minutes ago CGTN:Strengthening cultural ties: Peng Liyuan, Brigitte Macron visit Beijing People's Art Theatre
Published on 12/05/2025 at 12:00, 1 hour 32 minutes ago Iute Group: Successful Issue of Additional EUR 2025/2030 Bonds – Circulating Volume Increased to EUR 160 Million
Published on 12/05/2025 at 08:45, 4 hours 47 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 19 hours 32 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 19 hours 47 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 19 hours 48 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 6 hours ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health